1.Shekelle PG, Pronovost PJ, Wachter RM, Taylor SL, Dy SM, Foy R, et al. Advancing the science of patient safety. Annals of internal medicine. 2011;154(10):693–6.
2.de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Quality & safety in health care. 2008;17(3):216–23.
3.Davidoff F. Heterogeneity is not always noise: lessons from improvement. Jama. 2009;302(23):2580–6.
4.The Breakthrough Series: IHI’s Collaborative Model for Achieving Breakthrough Improvement. IHI Innovation Series white paper. 2003;Boston: Institute for Healthcare Improvement.
5.Nadeem E, Olin SS, Hill LC, Hoagwood KE, Horwitz SM. Understanding the Components of Quality Improvement Collaboratives: A Systematic Literature Review. The Milbank Quarterly. 2013;91(2):354–94.
6.Wells S, Tamir O, Gray J, Naidoo D, Bekhit M, Goldmann D. Are quality improvement collaboratives effective? A systematic review. BMJ Quality and Safety. 2017.
7.Ministry of Health. A Review of the National Orthopaedic Enhanced Recovery after Surgery (ERAS) Quality Improvement Collaborative: November 2013–March 2015. Wellington: Ministry of Health. 2017.
8.Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet (London, England). 2011;378(9800):1396–407.
9.Goodnough LT, Monk TG, Ozier Y, Slappendel R, Szpalski M, Maniatis A, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. BJA: British Journal of Anaesthesia. 2011;106(1):13–22.
10.Kotzé A, Harris A, Baker C, Iqbal T, Lavies N, Richards T, et al. British Committee for Standards in Haematology Guidelines on the Identification and Management of Pre-Operative Anaemia. British Journal of Haematology. 2015;171(3):322–31.
11.Munoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, et al. International consensus statement on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233–47.
12.Meybohm P, Richards T, Isbister J, Hofmann A, Shander A, Goodnough LT, et al. Patient Blood Management Bundles to Facilitate Implementation. Transfusion medicine reviews. 2017;31(1):62–71.
13.Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, Shander A, Richards T, Pavía J, et al. ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients†. British Journal of Anaesthesia. 2015;115(1):15–24.
14.Boralessa H, Goldhill DR, Tucker K, Mortimer AJ, Grant-Casey J. National Comparative Audit of Blood Use in Elective Primary Unilateral Total Hip Replacement Surgery in the UK. Annals of The Royal College of Surgeons of England. 2009;91(7):599–605.
15.Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–58.
16.Shander A, Van Aken H, Colomina MJ, Gombotz H, Hofmann A, Krauspe R, et al. Patient blood management in Europe. Br J Anaesth. 2012;109(1):55–68.
17.National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man. 15th Annual Report 2018: Surgical data to 31 December 2017. 2018.
18.Allepuz A, Serra-Sutton V, Martínez O, Tebé C, Nardi J, Portabella F, et al. Arthroplasty registers as post-marketing surveillance systems: The Catalan Arthroplasty Register. Revista Española de Cirugía Ortopédica y Traumatología (English Edition). 2013;57(1):27–37.
19.Sochart DH. The infected implant - what next? Praha: Triton; 2012. 111 p.
20.Zmistowski B PJ. A quarter of patients treated for PJI dead within 5 years. Orthopedics Today. 2013.
21.Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS. A financial analysis of revision hip arthroplasty. Journal of Bone and Joint Surgery, British Volume. 2012;94-B(5):619.
22.Vanhegan IS, Morgan-Jones R, Barrett DS, Haddad FS. Developing a strategy to treat established infection in total knee replacement. Journal of Bone and Joint Surgery, British Volume. 2012;94-B(7):875.
23.Chen AF, Wessel CB, Rao N. Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clinical orthopaedics and related research. 2013;471(7):2383–99.
24.Schweizer M, Perencevich E, McDanel J, Carson J, Formanek M, Hafner J, et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ: British Medical Journal. 2013;346.
25.World Health Organisation. Global guidelines for the prevention of surgical site infection. 2016:1–186.
26.Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clinical orthopaedics and related research. 2008;466(7):1710–5.
27.Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clinic proceedings. 2015;90(1):12–23.
28.Pujol-Nicolas A, Morrison R, Casson C, Khan S, Marriott A, Tiplady C, et al. Preoperative screening and intervention for mild anemia with low iron stores in elective hip and knee arthroplasty. Transfusion. 2017;57(12):3049–57.
29.Bhargava A, Salim M, Banavasi HV, Neelam V, Wenzel R, Sims KL, et al. Surgical Site Infections Following Birmingham Hip Resurfacing. Infection Control & Hospital Epidemiology. 2016;37(11):1383–6.
30.Borus T, Thornhill T. Unicompartmental knee arthroplasty. The Journal of the American Academy of Orthopaedic Surgeons. 2008;16(1):9–18.
31.Cook A, Cook S, Smith I, Weinrauch P. Hip resurfacing arthroplasty and perioperative blood testing. Adv Orthop. 2014;2014:109378-.
32.Marshall DA, Pykerman K, Werle J, Lorenzetti D, Wasylak T, Noseworthy T, et al. Hip resurfacing versus total hip arthroplasty: a systematic review comparing standardized outcomes. Clinical orthopaedics and related research. 2014;472(7):2217–30.
33.Torgerson DJ, Torgerson CJ. Designing Randomised Trials in Health, Education and the Social Sciences: Palgrave Macmillan; 2008.
34.Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ: British Medical Journal. 2015;351.
35.The National Joint Registry Editorial Board. 14th Annual Report National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. 2017.
36.Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. The New England journal of medicine. 2010;362(1):9–17.
37.Jeans E, Holleyman R, Tate D, Reed M, Malviya A. Methicillin sensitive staphylococcus aureus screening and decolonisation in elective hip and knee arthroplasty. Journal of Infection. 2018;77(5):405–9.
38.National Joint Registry. Best Practice Tarrif data January 2017 [Available from: HYPERLINK “www.njrcentre.org.uk/njrcentre/Healthcareproviders/NJRBestPracticeTariff/tabid/352/Default.aspx" www.njrcentre.org.uk/njrcentre/Healthcareproviders/NJRBestPracticeTariff/tabid/352/Default.aspx
39.Cook JA, Bruckner T, MacLennan GS, Seiler CM. Clustering in surgical trials—database of intracluster correlations. Trials. 2012;13:2.
40.West Midlands RTC Audit Group TC, Blest A, Lumley M, Hartley J, Baker C, Pailing M. Audit of Blood Use in Orthopaedic Surgery Comparative Report. West Midlands Regional Transfusion Committee. March 2005:1–15.
41.Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. Journal of orthopaedic surgery and research. 2015;10:48.
42.Monitor and NHS Trust Development Authority. Learning from mistakes league. 9 March 2016:12.
43.Saghaei M, Saghaei S. Implementation of an open-source customizable minimization program for allocation of patients to parallel groups in clinical trials. Journal of Biomedical Science and Engineering. 2011;4, 734–739.
44.Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clinical research ed). 2014;348:g1687.
45.Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ quality & safety. 2016;25(12):986–92.
46.Public Health England. Protocol for the Surveillance of Surgical Site Infection. LondonJune 2013. p. 82.
47.Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ (Clinical research ed). 2012;345:e5661.
48.Dixon-Woods M, McNicol S, Martin G. Ten challenges in improving quality in healthcare: lessons from the Health Foundation’s programme evaluations and relevant literature. BMJ Quality and Safety. 2012;21(10):876.